Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2020BMJ Open GastroenterologyOpen Access

Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia

View Full Paper
Ask AI
Bookmark
Share

Authors

ИМИ. В. МаевАСА А СамсоновLPLiudmila K Palgova

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Маев et al. (2020) studied this question.

synapsesocial.com/papers/6aa2b5d43c35dfb37e20746ehttps://doi.org/10.1136/bmjgast-2019-000368
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values2003 · 1,208 citations
  2. 2Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes2015 · 153 citations
  3. 3Polyenylphosphatidylcholine Decreases Alcohol‐Induced Oxidative Stress in the Baboon1997 · 138 citations
  4. 4Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound2016 · 18 citations
  5. 5Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic2014 · 190 citations